Intramammary Dosage Form New Animal Drugs; Pirlimycin
other · Food and Drug Administration · Rule · Published 2008-01-04 · Effective 2008-01-04 · 73 FR 811
Document
Document number
E7-25606
Federal Register citation
73 FR 811
CFR reference
21 CFR 526
Type
Rule
Action
Final rule.
Category
other
Sub-agency
Food and Drug Administration
Publication date
2008-01-04
Effective date
2008-01-04
Abstract
The Food and Drug Administration (FDA) is amending the animal drug regulations to reflect approval of a supplemental new animal drug application (NADA) filed by Pharmacia and Upjohn Co., a Division of Pfizer, Inc. The supplemental NADA extends the dosage regimen for pirlimycin hydrochloride intramammary infusion in lactating dairy cattle to daily treatment for up to 8 days.